Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2023

Mar 21, 2023

33339_dirs_2023-03-21_dcd71f6d-02d6-4f6a-a419-389b57e6396b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2023-03-17

Reporting Person: McMahon Rebecca E (President - R&D)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-17 Common Stock F 201 $41.50 Disposed 9595 Direct

Footnotes

F1: Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of 682 shares of restricted stock granted to the reporting person on March 8, 2022. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.